UK-US Agree Zero Tariff Deal on Medicines
The UK and US have agreed a three-year deal to maintain 0% tariffs on pharmaceuticals, aiming to boost trade and secure NHS access to new treatments. Read the full details.
Category : Search result: pharmaceutical investment
Prince William: Wales a 'Dynamic Nation' for Investment
The Prince of Wales addressed global investors in Newport, hailing Wales's tech and green energy potential and sharing personal memories of making his first home with Catherine on Anglesey.
UK-US agree zero tariff deal on pharmaceuticals
The UK and US have struck a deal to maintain 0% tariffs on medicines for three years, alongside NHS commitments to increase spending on new drugs. Discover the implications for patients and industry.
William Urges Investors to Seize 'Extraordinary' Welsh Potential
Prince William urged global investors to seize the 'extraordinary possibility' in Wales at a major summit, praising the King's legacy and highlighting the nation's clean energy and tech sectors.
NHS drug costs to rise 25% in US trade deal
The NHS will pay 25% more for new medicines under a UK-US trade agreement, costing taxpayers £3bn. The deal secures zero tariffs for UK pharmaceutical exports to America. Discover the full impact.
UK-US set for zero-tariff pharma deal amid NHS price row
The UK is poised to strike a deal with the US removing tariffs on pharmaceuticals, following warnings of investment cuts. The agreement hinges on the NHS paying more for American medicines. Read the full details.
William Champions Wales at Major Investment Summit
The Prince of Wales will address over 250 firms at a landmark summit in Newport, promoting Wales as a hub for tech, innovation, and skilled talent. Discover the key sectors and opportunities.
Samsung pledges £310bn domestic investment post-US deal
Samsung and Hyundai announce massive domestic investment plans in South Korea following a new US trade agreement that averts Trump-era tariffs. Discover the economic implications.
Millionaire flees Australia, warns property dream is over
Matt Cameron sold his entire Australian property portfolio after audit revealed poor returns. He now lives luxuriously in Bali and urges others to follow his investment strategy abroad.
ADHD medication recalled over effectiveness issues
A popular generic ADHD medication is being recalled nationwide after tests showed it may not dissolve properly, failing to deliver the full dose. Patients urged to check their prescriptions.
Big Pharma's Tax Breaks: Calls for Transparency Grow
Pharmaceutical giants face mounting pressure to justify massive tax incentives amid concerns over NHS funding and pandemic-era profit surges. Westminster demands clarity on whether public investment delivers fair returns.
UK probes Pfizer and Novo Nordisk investments
The UK government launches a national security probe into major pharmaceutical investments by US-based Pfizer and Denmark's Novo Nordisk, raising concerns about foreign influence in Britain's vital healthcare sector.
UK patients face treatment delays in pharma pricing crisis
A bitter pricing dispute between the UK government and pharmaceutical companies threatens to delay vital new medicines for NHS patients, with industry leaders warning of an escalating crisis.
GSK chief warns UK drug pricing reforms threaten industry
Emma Walmsley warns that proposed NHS drug pricing reforms could devastate Britain's pharmaceutical industry and drive investment overseas in stark government warning.
Gold Rally Warning: Prices Falling as Experts Predict Bust
Investment professionals sound alarm as gold's spectacular rally shows signs of cracking. Discover why the precious metal's sudden decline could signal deeper market troubles ahead.
Rachel Reeves courts Gulf states for UK investment
Chancellor Rachel Reeves is actively seeking investment from Gulf nations including Saudi Arabia, raising questions about economic pragmatism versus ethical foreign policy in Labour's new government.
WHO Alert: Contaminated Cough Syrups Linked to Child Deaths
The World Health Organization issues urgent global warning after contaminated cough syrups are connected to dozens of child fatalities across several nations. Health authorities worldwide are scrambling to remove dangerous medications from circulation.
Opium painkiller returns to England and Wales after 50 years
In a landmark pharmaceutical reversal, the opium-based pain medication Opium is set to be reintroduced in England and Wales after being withdrawn from the market nearly five decades ago, offering new hope for chronic pain sufferers.
Native Americans denied diabetes drugs amid weight loss craze
Native American communities face critical shortages of diabetes medications like Ozempic as wealthy New Yorkers exploit prescriptions for weight loss, creating a healthcare crisis for vulnerable populations.
AstraZeneca cuts drug prices for NHS in Trump-backed deal
Pharmaceutical giant AstraZeneca agrees to major price reductions on life-saving medications for NHS patients in unprecedented deal supported by former President Trump, promising significant savings for Britain's healthcare system.
Trump pressured AstraZeneca on US drug prices
Exclusive investigation reveals how Donald Trump pressured AstraZeneca to slash US drug prices while keeping UK costs high, exposing stark transatlantic healthcare divide.
AstraZeneca to Provide Cancer Drugs to Medicaid Patients
In a groundbreaking healthcare development, AstraZeneca announces it will provide expensive cancer medications to low-income Americans through Medicaid, challenging pharmaceutical industry norms.
Trump Claims AstraZeneca COVID Drug Discount Amid Questions
Former President Donald Trump announces dramatic price reduction for AstraZeneca's COVID-19 antibody treatment, but details remain scarce and verification proves challenging.
Trump: Big Pharma 'held NHS to ransom' on vaccines
Former US President Donald Trump makes explosive allegations about pharmaceutical companies exploiting the NHS during pandemic negotiations, claiming Britain paid 'far more than other countries' for COVID vaccines.
Lloyds Bank makes £450m profit from Ferrari stake sale
Exclusive analysis reveals how Lloyds Banking Group's patient investment strategy paid off spectacularly with their Ferrari stake, while Citigroup faces Hong Kong regulatory scrutiny in separate banking sector developments.
Indian pharma execs arrested in cough syrup death scandal
Indian authorities have detained three pharmaceutical executives following an investigation into contaminated cough syrup allegedly responsible for numerous child deaths in Cameroon.
Gold Investment Surge on London's AIM Market Amid Uncertainty
London's AIM market sees unprecedented gold investment surge as pandemic fears and economic instability drive investors toward traditional safe-haven assets. Expert analysis reveals shifting market trends.
Trump's NHS Trade Deal Bombshell Exposed
Exclusive investigation reveals Donald Trump's plans to put NHS on the table in US trade negotiations, raising alarm about drug prices and American corporate influence on Britain's healthcare system.
Trump Tariffs Threaten NHS Drug Price Crisis
Former President Donald Trump's proposed tariffs could dramatically increase costs for NHS medicines, potentially costing the health service billions and threatening patient care across the UK.
RFK Jr's Bizarre Ozempic Sugar Conspiracy Theory
Independent presidential candidate Robert F. Kennedy Jr has sparked controversy by suggesting diabetes and weight-loss medications like Ozempic are part of a conspiracy to eliminate sugar from American diets. His unconventional claims about artificial swe
Page 1 of 4